Clinical Trials Logo

Stage IB1 Cervical Cancer clinical trials

View clinical trials related to Stage IB1 Cervical Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04219904 Active, not recruiting - Clinical trials for Stage IB Cervical Cancer

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Start date: September 7, 2018
Phase: Early Phase 1
Study type: Interventional

This trial studies how well positron emission tomography/magnetic resonance imaging (PET/MRI) scan works in checking patients with stage IA1-IB3 cervical cancer that can be removed by surgery (resectable). PET/MRI scan may help doctors learn more about the spread of the disease.

NCT ID: NCT02323841 Active, not recruiting - Clinical trials for Stage IB1 Cervical Cancer

Feasibility Study: Conservative Treatment in Cervical Cancer

Start date: March 2014
Phase: Phase 0
Study type: Interventional

Currently conservative treatment for patients of childbearing affected by cervical cancer is reserved for women with FIGO stage IA2 - IB1 with tumor size less than 2 cm . The trachelectomy and the cone biopsy with pelvic lymphadenectomy are the choice for these patients wishing to preserve their reproductive function. In this context , recently literature show the results about the use of neo-adjuvant chemotherapy about the reduction of tumor volume and therefore the magnitude of the subsequent surgical treatment (including patients with tumors larger than 2 cm ). So it becomes crucial a prospective analysis on the possibility to include in this type of treatment patients with stage IB1 and IIA1 with tumor size greater than 2 cm ( up to 4 cm ) . The current study , in fact , would like to do a prospective evaluation on the advantages of neo-adjuvant chemotherapy in the possibility of broadening the inclusion criteria to conservative treatment in women , suffering from cervical cancer, stage IB1 and IIA1 ( with tumor volume between 2 and 4 cm) and wishing to preserve their reproductive function.